260 related articles for article (PubMed ID: 22353833)
81. Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women.
Zakaria D; Shaw A
Cancer Causes Control; 2019 Feb; 30(2):137-147. PubMed ID: 30637599
[TBL] [Abstract][Full Text] [Related]
82. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.
Ripping TM; Verbeek AL; Ten Haaf K; van Ravesteyn NT; Broeders MJ
Cancer Epidemiol; 2016 Jun; 42():147-53. PubMed ID: 27153471
[TBL] [Abstract][Full Text] [Related]
83. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
[TBL] [Abstract][Full Text] [Related]
84. Growth rate of invasive ductal carcinomas from a screened 50-74-year-old population.
Otten JD; van Schoor G; Peer PG; den Heeten GJ; Holland R; Broeders MJ; Verbeek AL
J Med Screen; 2018 Mar; 25(1):40-46. PubMed ID: 28084888
[TBL] [Abstract][Full Text] [Related]
85. Increased diagnosis and detection rates of carcinoma in situ of the breast.
Glover JA; Bannon FJ; Hughes CM; Cantwell MM; Comber H; Gavin A; Deady S; Murray LJ
Breast Cancer Res Treat; 2012 Jun; 133(2):779-84. PubMed ID: 22331483
[TBL] [Abstract][Full Text] [Related]
86. Overdiagnosis and overtreatment of breast cancer: overdiagnosis and overtreatment in service screening.
Paci E; Duffy S
Breast Cancer Res; 2005; 7(6):266-70. PubMed ID: 16457702
[TBL] [Abstract][Full Text] [Related]
87. Evaluating different breast tumor progression models using screening data.
Westvik ÅS; Weedon-Fekjær H; Mæhlen J; Liestøl K
BMC Cancer; 2018 Feb; 18(1):209. PubMed ID: 29463227
[TBL] [Abstract][Full Text] [Related]
88. The impact of breast cancer screening among younger women in the Barretos Region, Brazil.
De Castro Mattos JS; Mauad EC; Syrjänen K; Longatto-Filho A; Haikel RL; Da Costa Vieira RA; Silva TB; De Barros N
Anticancer Res; 2013 Jun; 33(6):2651-5. PubMed ID: 23749923
[TBL] [Abstract][Full Text] [Related]
89. Screening Mammography in Women 40-49 Years Old: Current Evidence.
Ray KM; Joe BN; Freimanis RI; Sickles EA; Hendrick RE
AJR Am J Roentgenol; 2018 Feb; 210(2):264-270. PubMed ID: 29064760
[TBL] [Abstract][Full Text] [Related]
90. Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme.
Schouten LJ; de Rijke JM; Huveneers JA; Verbeek AL
J Med Screen; 2002; 9(3):120-4. PubMed ID: 12370323
[TBL] [Abstract][Full Text] [Related]
91. [Screening mammography may be a rapid and effective investigation of mamma cancer in asymptomatic women].
Larsen MB; Langagergaard V; Larsson H; Mikkelsen EM; Andersen B
Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293859
[TBL] [Abstract][Full Text] [Related]
92. [Natural history of breast cancer: a systematic review of worldwide randomized controlled trials of mammography screening].
Yue XP; Shi JF; Mao AY; Wang L; Ma HM; Chen LL; Zhu J; Cheng X; Dai M
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):154-160. PubMed ID: 28219215
[No Abstract] [Full Text] [Related]
93. Detection of breast cancer with mammography in the first screening round in relation to expected incidence in different age groups.
Jonsson H; Larsson LG; Lenner P
Acta Oncol; 2003; 42(1):22-9. PubMed ID: 12665327
[TBL] [Abstract][Full Text] [Related]
94. Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme.
Peeters PH; Verbeek AL; Straatman H; Holland R; Hendriks JH; Mravunac M; Rothengatter C; Van Dijk-Milatz A; Werre JM
Int J Epidemiol; 1989 Jun; 18(2):295-9. PubMed ID: 2788627
[TBL] [Abstract][Full Text] [Related]
95. The potential impact of breast cancer screening in Hong Kong.
Lau Y; Lau PY; Chan CM; Yip A
Aust N Z J Surg; 1998 Oct; 68(10):707-11. PubMed ID: 9768606
[TBL] [Abstract][Full Text] [Related]
96. Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP).
de Silva D; Gilbert F; Needham G; Deans H; Turnpenny P; Haites N
J Med Genet; 1995 Nov; 32(11):862-6. PubMed ID: 8592328
[TBL] [Abstract][Full Text] [Related]
97. Assessment of potential risk factors for breast cancer in a population in Southern Brazil.
Breyer JZ; Wendland EM; Kops NL; Caleffi M; Hammes LS
Breast Cancer Res Treat; 2018 May; 169(1):125-131. PubMed ID: 29344741
[TBL] [Abstract][Full Text] [Related]
98. Quantifying the natural history of breast cancer.
Tan KH; Simonella L; Wee HL; Roellin A; Lim YW; Lim WY; Chia KS; Hartman M; Cook AR
Br J Cancer; 2013 Oct; 109(8):2035-43. PubMed ID: 24084766
[TBL] [Abstract][Full Text] [Related]
99. Summaries for patients: Overdiagnosis of invasive breast cancer with mammography screening.
Ann Intern Med; 2012 Apr; 156(7):I58. PubMed ID: 22473444
[No Abstract] [Full Text] [Related]
100. Breast cancer incidence and overdiagnosis in Catalonia (Spain).
Martinez-Alonso M; Vilaprinyo E; Marcos-Gragera R; Rue M
Breast Cancer Res; 2010; 12(4):R58. PubMed ID: 20682042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
